Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.

You are here:Home-SARS-CoV-2 Related-SARS-CoV-2 Antibodies-Etesevimab
Etesevimab

Chemical Structure : Etesevimab

CAS No.:

Etesevimab (LY-CoV016, JS016)

Catalog No.: PC-38882Not For Human Use, Lab Use Only.

Etesevimab (LY-CoV016, JS016) is a recombinant fully human monoclonal neutralizing antibody, specifically binds to the SARS-CoV-2 surface spike protein receptor binding domain (RBD) with high affinity and can block the binding of the virus to the ACE2 host cell surface receptor.

Packing Price Stock Quantity
1 mg Get quote
5 mg Get quote
10 mg Get quote
25 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

Etesevimab (LY-CoV016, JS016) is a recombinant fully human monoclonal neutralizing antibody, specifically binds to the SARS-CoV-2 surface spike protein receptor binding domain (RBD) with high affinity and can block the binding of the virus to the ACE2 host cell surface receptor.

Isotype: IgG1-kappa.
Anti-[human severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein, receptor binding domain (RBD)], human monoclonal antibody.

Physicochemical Properties

M.Wt
Formula
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

References

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: